Article section
The Role of Global Collaboration in Combating Future Pandemics: Lessons from COVID-19
Abstract
The COVID-19 pandemic underscored the critical importance of global collaboration in managing and mitigating the spread of infectious diseases. It revealed strengths in certain aspects of global health cooperation, such as vaccine development, while also exposing gaps in pandemic preparedness, response coordination, and equitable access to healthcare resources. This paper examines the role of global collaboration in combating future pandemics, focusing on key lessons learned from the COVID-19 crisis. It highlights the importance of strengthening international health frameworks, enhancing data sharing, building resilient health systems, and ensuring equitable distribution of vaccines and medical resources. By examining both successes and challenges from COVID-19, the paper offers strategic recommendations to better prepare for future pandemics.
Article information
Journal
Frontiers in Global Health Sciences
Volume (Issue)
3 (1)
Pages
23-32
Published
Copyright
Copyright (c) 2024 Ian Park (Author)
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Bollyky, T. J., Gostin, L. O., & Hamburg, M. A. (2020). The equitable distribution of COVID-19 therapeutics and vaccines. *The Lancet*, 396(10255), 32398-32400. https://doi.org/10.1016/S0140-6736(20)32398-X
Fidler, D. P. (2020). Global health governance and the WHO: Lessons from the COVID-19 pandemic. *Annual Review of Public Health*, 41, 501-513. https://doi.org/10.1146/annurev-publhealth-040617-013507
Gostin, L. O., Friedman, E. A., & Wetter, S. A. (2020). Responding to COVID-19: How to navigate a public health emergency legally and ethically. *JAMA*, 323(15), 1545-1546. https://doi.org/10.1001/jama.2020.16936
Hassan, I., Mukaigawara, M., King, L., Fernandes, G., & Sridhar, D. (2021).The COVID-19 response in low- and middle-income countries: Vaccine equity and the role of global health governance. *The Lancet*, 397(10278), 1395-1398. https://doi.org/10.1016/S0140-6736(21)00576-6
Heymann, D. L., Shindo, N., & WHO Scientific and Technical Advisory Group for Infectious Hazards. (2021). COVID-19: What is next for public health? *The Lancet*, 398(10243), 347-349. https://doi.org/10.1016/S0140-6736(21)01234-2
Khoury, M. J., Engelgau, M. M., & Mensah, G. A. (2020). Global surveillance, big data, and predicting the pandemic risks of COVID-19. *Nature Medicine*, 27(1), 26-27. https://doi.org/10.1038/s41591-021-01410-w
So, A. D., & Woo, J. (2021). Reserving coronavirus disease 2019 vaccines for global access: Cross-sectional analysis. *The Lancet*, 397(10281), 245-251. https://doi.org/10.1016/S0140-6736(21)00249-6
Yamey, G., Garcia, P., Hassan, I., Mao, W., McDade, K. K., & Pai, M. (2021). Ensuring global access to COVID-19 vaccines. *The Lancet*, 397(10279), 562-563. https://doi.org/10.1016/S0140-6736(21)00670-5
World Health Organization (WHO). (2021). World Health Organization Coronavirus (COVID-19) Dashboard. *World Health Organization*. https://doi.org/10.1056/NEJMoa2035389